Impaired Langerhans cell migration in psoriasis

Marie Cumberbatch1, Minal Singh, Rebecca J Dearman

  • 1Syngenta Central Toxicology Laboratory, Macclesfield, Cheshire, SK10 4TJ, England, UK.

Insights

Psoriasis patients show impaired epidermal Langerhans cell (LC) migration. This defect in LC function, despite normal cell appearance, suggests a key role in psoriasis pathogenesis.

Area of Science:

  • Immunodermatology
  • Cutaneous Immunology

Background:

  • Psoriasis is a chronic inflammatory skin disease.
  • Langerhans cells (LCs) are critical immune cells in the epidermis, involved in initiating immune responses.
  • Systemic effects on LC function in psoriasis are not fully understood.

Purpose of the Study:

  • To investigate systemic effects of psoriasis on epidermal LC function.
  • To specifically assess the migratory capacity of LCs from uninvolved psoriatic skin.

Main Methods:

  • Comparison of LC frequency and morphology in uninvolved psoriatic skin versus normal skin.
  • Assessment of LC mobilization in response to chemical allergens, TNF-alpha, and IL-1beta.
  • Evaluation of receptor expression for IL-1beta and TNF-alpha on LCs.
  • Analysis of induced cutaneous cytokine expression.

Main Results:

  • Epidermal LCs in uninvolved psoriatic skin had normal frequency and morphology.
  • LC mobilization was significantly impaired in response to stimuli like TNF-alpha and IL-1beta.
  • This impaired migration was observed despite comparable inflammatory reactions in patients and controls.
  • Altered expression of cytokine receptors or induced cytokine expression did not explain the migration defect.

Conclusions:

  • Psoriasis is associated with a consistent defect in epidermal LC function, specifically their migration.
  • This impaired LC migration may be a crucial factor in the pathogenesis of psoriasis.
  • Further research is needed to fully elucidate the dynamics of LC migration and turnover in psoriasis.